The Business Research Company’s report on the Sepsis Diagnostics Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the primary drivers fueling the growth of the sepsis diagnostics market in recent years?
The rising incidence of hospital-acquired infections is expected to propel the growth of the sepsis diagnostics market going forward. Hospital-acquired infections (HAIs) are infections that develop during or after a patient’s stay in a healthcare facility, typically 48 hours or more after admission, and were not present at the time of admission. The rising incidence of hospital-acquired infections is due to an increase in antibiotic resistance. Overuse and misuse of antibiotics in healthcare settings led to the development of resistant bacteria, making infections harder to treat. Sepsis diagnostics helps detect hospital-acquired infections early by identifying pathogens and biomarkers, enabling timely treatment and reducing complications. For instance, in November 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2022–23, HACs were observed in 2% of public hospital admissions and 0.8% of private hospital admissions, with healthcare-associated infections being the most frequent complication. Therefore, the rising incidence of hospital-acquired infections drives growth in the sepsis diagnostics market.
Access Your Free Sample of the Global Sepsis Diagnostics Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=23514&type=smp
What is the projected market size of the sepsis diagnostics industry, and how is it expected to grow?
The sepsis diagnostics market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.07 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing incidence of sepsis, growing awareness about early diagnosis, rising healthcare expenditure, growing prevalence of hospital-acquired infections, and increasing adoption of point-of-care testing.
The sepsis diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to rising demand for rapid diagnostics, increasing investments in healthcare infrastructure, growing focus on personalized medicine, increasing prevalence of antimicrobial resistance, and rising use of next-generation sequencing. Major trends in the forecast period include integration of AI in diagnostics, technological advancements in biomarkers, advancements in molecular diagnostics, shift towards automated and digital diagnostic platforms, and advancement of artificial intelligence in diagnostics.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=23514&type=smp
Who are the key players driving competition in the sepsis diagnostics market?
Major companies operating in the sepsis diagnostics market are Siemens Healthcare GmbH, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., GE Healthcare, Wolters Kluwer N.V., bioMérieux S.A., Bruker Corporation, DiaSorin S.p.A., Cepheid Inc., Seegene Inc., Luminex Corporation, T2 Biosystems Inc., Cytovale Inc., Accelerate Diagnostics Inc., Immunexpress Inc., Sepsis Alliance
What trends will shape the future of the semiconductor process control equipment market?
Major companies operating in the sepsis diagnostics market are focusing on developing innovative solutions, such as culture-free diagnostic solutions, to enable rapid and accurate detection of sepsis without relying on traditional blood cultures. A culture-free diagnostic solution is a method of detecting pathogens or infections without the need for traditional microbial culture techniques. These solutions rely on advanced technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), or immunoassays to rapidly identify pathogens directly from patient samples such as blood, saliva, or tissue. For instance, in April 2024, Deepull Diagnostics S.L., a Spain-based manufacturing company, launched the UllCORE diagnostic system for early sepsis detection. The UllCORE system is a benchtop, culture-free multiplex PCR platform developed by Deepull for rapid pathogen identification in sepsis and other acute infections. It extracts microbial DNA from 8 mL of whole blood and provides 50 reportable results within one hour. The system detects 95% of sepsis-causing pathogens, including bacteria, fungi, and antibiotic resistance genes. Designed to improve early diagnosis and reduce antibiotic misuse, UllCORE supports hospitals combating antimicrobial resistance.
Which key geographies are driving the growth of the sepsis diagnostics market?
North America was the largest region in the sepsis diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/sepsis-diagnostics-global-market-report
What are the key segments driving growth in the sepsis diagnostics market?
The sepsis diagnostics market covered in this report is segmented –
1) By Product: Instruments, Blood Culture Media, Assay Kits And Reagents, Software
2) By Technology: Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, Other Technologies
3) By Pathogen: Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, Other Pathogens
4) By Method: Automated Diagnostics, Conventional Diagnostics
5) By End-Users: Hospitals And Clinics, Pathology And Reference Laboratories, Research Institutes
Subsegments:
1) By Instruments: Automated Analyzers, Point-Of-Care (PoC) Testing Devices, Microfluidic-Based Devices, Polymerase Chain Reaction (PCR) Instruments, Flow Cytometers
2) By Blood Culture Media: Aerobic Blood Culture Media, Anaerobic Blood Culture Media, Mycobacteria Blood Culture Media, Pediatric Blood Culture Media, Fungal Blood Culture Media
3) By Assay Kits And Reagents: Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Polymerase Chain Reaction (PCR) Assay Kits, Immunoassay Reagents, Molecular Diagnostic Reagents, Biosensor-Based Assay Kits
4) By Software: Data Management Software, Laboratory Information Systems (LIS), Artificial Intelligence (AI)-Based Diagnostic Tools, Predictive Analytics Software, Cloud-Based Diagnostic Platforms
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23514
How is the sepsis diagnostics market defined, and what are its core characteristics?
Sepsis diagnostics refers to a range of advanced technologies and tests designed to quickly detect the presence of sepsis, a critical condition that can lead to organ failure and death if left untreated. These technologies enable healthcare providers to assess the severity of the condition and make timely, informed decisions to initiate appropriate treatment and improve patient survival rates.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
